Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acquired | Acquired

Total Raised




About Prism Pharmaceuticals

Prism Pharmaceuticals is an acute care pharmaceutical company engaged in developing and commercializing cardiovascular injectable products.

Prism Pharmaceuticals Headquarters Location

1150 First Avenue Suite 1050

King Of Prussia, Pennsylvania, 19406,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Prism Pharmaceuticals Patents

Prism Pharmaceuticals has filed 2 patents.

The 3 most popular patent topics include:

  • Diseases of liver
  • Glycoproteins
  • Hepatology
patents chart

Application Date

Grant Date


Related Topics




Clusters of differentiation, Immune system, Immunology, Cancer treatments, Transcription factors


Application Date


Grant Date



Related Topics

Clusters of differentiation, Immune system, Immunology, Cancer treatments, Transcription factors



  • When was Prism Pharmaceuticals founded?

    Prism Pharmaceuticals was founded in 2004.

  • Where is Prism Pharmaceuticals's headquarters?

    Prism Pharmaceuticals's headquarters is located at 1150 First Avenue, King Of Prussia.

  • What is Prism Pharmaceuticals's latest funding round?

    Prism Pharmaceuticals's latest funding round is Acquired.

  • How much did Prism Pharmaceuticals raise?

    Prism Pharmaceuticals raised a total of $30.4M.

  • Who are the investors of Prism Pharmaceuticals?

    Investors of Prism Pharmaceuticals include Baxter International, EW Healthcare Partners, HealthCare Royalty Partners and Paul Capital Partners.

  • Who are Prism Pharmaceuticals's competitors?

    Competitors of Prism Pharmaceuticals include Ology Bioservices, Aegerion Pharmaceuticals, Collegium Pharmaceutical, Salix Pharmaceuticals, Conatus Pharmaceuticals and 9 more.

You May Also Like


VGXI is a contract manufacturer of plasmid DNA. The company delivers flexibility, experience, reliability, and value to clients’ challenging programs. The company’s cGMP and non-cGMP products have passed rigorous international regulatory reviews.

IVREA Pharmaceuticals

IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. IVREA's pharmaceuticals leverage topical delivery technologies.


Relevare Pharmaceuticals, formerly CNSBio, is a specialty pharmaceutical company focused on the development of novel therapies to treat chronic and acute pain. Relevare Pharmaceuticals exciting clinical-stage pipeline is comprised of programs that combine or reposition drugs known to be active at CNS targets that modulate pain perception and transmission, and for which there is strong safety evidence in humans. In April 2010, CNSBio rebranded to Relevare Pharmaceuticals.

Ikano Therapeutics

Ikano Therapeutics is a specialty pharmaceutical company focused on developing nasally delivered pharmaceutical products with a particular focus on drugs treating pain and disorders related to the central nervous system.

Neurelis Logo

Neurelis is a specialty pharmaceutical company that devleops and commercializes product candidates for epilepsy and the broader central nervous system (CNS) market.

Pondera Pharmaceuticals

Pondera Pharmaceutical is a stealth mode pharmaceuticals company.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.